Advertisement
Screener

MeiraGTx Holdings plc (MGTX) Net Margin

MeiraGTx Holdings plc (MGTX) Net Margin

  • 2026-06-30: Net Margin 50.00%.
  • 2026-03-31: Net Margin -15806.48%.
  • 2025-12-31: Net Margin 20.02%.
  • 2025-09-30: Net Margin -12320.24%.

Complete source-backed net margin history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3050.00%
2026-03-31-15806.48%
2025-12-3120.02%
2025-09-30-12320.24%
2025-06-30-1051.07%
2025-03-31-2075.86%
2024-12-31-184.19%
2024-09-30-360.49%
2024-06-30-17241.13%
2024-03-31-2932.86%
2023-12-31990.93%
2023-09-30-868.06%
2023-06-30-835.62%
2023-03-31-910.74%
2022-12-31516.51%
2022-09-30-774.17%
2022-06-30-315.76%
2022-03-31-551.13%
2021-12-31-47.10%
2021-09-30-373.42%
2021-06-30-392.61%
2021-03-31-513.99%
2020-12-31-276.16%
2020-09-30-126.32%
2020-06-30-1027.41%
2020-03-31-372.47%
2019-12-31-78.95%
2019-09-30-291.99%
2019-06-30-1050.75%
2019-03-31-2290.81%

Annual Net Margin

DateNet Margin
2025-12-31-140.31%
2024-12-31-444.10%
2023-12-31-599.46%
2022-12-31-814.16%
2021-12-31-211.03%
2020-12-31-372.63%
2019-12-31-411.87%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10